[The Correlation Between MicroRNAs in Serum and the Extent of Liver Injury]

Yi-Nan Zuo1,2, Xue-Ling He2, Xue-Ni Shi1,2

  • 1College of Life Sciences, Sichuan University, Chengdu 610065, China.

Abstract

Insights

Serum miR-122 and miR-192 levels accurately indicate acute liver injury severity in animal models. These microRNAs (miRNAs) show a strong correlation with liver damage, aiding in diagnosis and monitoring of drug-induced liver injury (DILI).

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Toxicology

Background:

  • Acute liver injury (ALI) poses a significant health concern, necessitating reliable biomarkers for diagnosis and monitoring.
  • MicroRNAs (miRNAs) are small non-coding RNAs with critical roles in gene regulation and are increasingly recognized as potential biomarkers for various diseases, including liver injury.

Purpose of the Study:

  • To investigate the correlation between serum levels of specific microRNAs (miR-122, miR-451, miR-92a, miR-192) and the extent of acute liver injury in rat and mouse models.
  • To assess the relationship between these serum microRNAs and the drug-induced liver injury pathological scoring system (DILI-PSS).

Main Methods:

  • Established rat models of carbon tetrachloride (CCl4)-induced ALI and mouse models of acetaminophen (APAP)-induced ALI.
  • Collected serum samples at various time points post-induction and quantified miRNA absolute levels using the MiRbay SV miRNA Assay kit.
  • Analyzed liver tissue pathology to correlate miRNA levels with injury severity.

Main Results:

  • Serum miR-122 and miR-192 levels significantly increased in both CCl4-induced rat and APAP-induced mouse ALI models, peaking at 24 hours and returning to baseline by 72 hours.
  • miR-122 and miR-192 demonstrated a strong positive correlation with the DILI-PSS (r=0.7413, P<0.05; r=0.7883, P<0.01, respectively).
  • Changes in miR-92a and miR-451 levels were less consistent or showed gradual decline in specific models.

Conclusions:

  • Absolute quantification of serum miR-122 and miR-192 serves as a reliable indicator of acute liver injury, with levels peaking at 24 hours and decreasing by 72 hours.
  • These two microRNAs exhibit a significant positive correlation with DILI-PSS, particularly in APAP-induced liver injury models.
  • miR-122 and miR-192 are promising biomarkers for assessing the severity of drug-induced and chemical liver injuries.